Glucotrack announces 1-for-20 reverse stock split to regain Nasdaq compliance effective Feb 4, 2025

Glucotrack, Inc.

1-for-20 reverse split effective at market open on Feb 4, 2025; shares reduce from ~155.5M to ~7.77M.
No fractional shares issued; holders receive additional fraction to round up to whole share.
Board approved 1-for-20 ratio on Jan 28, 2025, following stockholder authorization on Jan 3, 2025.
Reverse split intended to meet Nasdaq $1.00 minimum bid price requirement and attract institutional investors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.